What is Oasis?
Oasis stands as a leading fertility hospital, recognized for its world-class treatment offerings in Hyderabad and Chennai. The institution specializes in a comprehensive suite of reproductive health services, including Women's Infertility, In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI) Treatment, Surrogacy, and Egg & Sperm Donation. The company's commitment to advanced fertility solutions positions it as a key player in the rapidly evolving healthcare landscape, addressing critical needs in reproductive medicine.
How much funding has Oasis raised?
Oasis has raised a total of $56.2M across 2 funding rounds:
Private Equity
$6.2M
Private Equity
$50M
Private Equity (2016): $6.2M, investors not publicly disclosed
Private Equity (2022): $50M led by Kedaara Capital
Key Investors in Oasis
Kedaara Capital
Kedaara Capital is a leading investment management company based in Mumbai, India, specializing in private equity with a focus on growth-oriented strategic and minority investments. The firm combines skilled investment judgment with extensive operational experience to support its portfolio companies in realizing their full potential.
What's next for Oasis?
The recent major strategic investment into Oasis signals a pivotal phase of scaling and market penetration. With a foundation built on comprehensive fertility treatments and a strong presence in key Indian cities, the company is poised to leverage this capital for further innovation and service expansion. Future endeavors will likely focus on enhancing patient care, potentially expanding its geographical footprint, and integrating cutting-edge technologies to maintain its leadership in the fertility treatment sector. This financing round is expected to accelerate Oasis's mission to provide accessible and effective reproductive healthcare solutions.
See full Oasis company page
